Literature DB >> 17456223

Contribution of Ara h 2 to peanut-specific, immunoglobulin E-mediated, cell activation.

R A McDermott1, H S Porterfield, R El Mezayen, A W Burks, L Pons, D G Schlichting, B Solomon, J S Redzic, R J Harbeck, M W Duncan, K C Hansen, S C Dreskin.   

Abstract

BACKGROUND: Ara h 2 is a potent peanut allergen but its contribution to the ability of a crude peanut extract (CPE) to cross-link IgE and activate mast cells has not been rigorously evaluated.
OBJECTIVE: To measure the contribution that Ara h 2 makes to the effector function of a CPE.
METHODS: Ara h 2 was specifically removed from a CPE as demonstrated by immunoblots, 2D gels, and an inhibitory ELISA. Functional assays of sham-treated and Ara h 2-depleted CPEs were performed with RBL SX-38 cells sensitized with IgE from highly peanut-allergic subjects and with naturally sensitized basophils.
RESULTS: Depletion of approximately 99% of the Ara h 2 from the CPE led to an increase in the concentration of the CPE necessary to give 50% of maximal degranulation (EC50) of the SX-38 cells following sensitization with sera that contain anti-Ara h 2 IgE. Assays with a pool of 10 sera showed a small but significant increase in the EC50 following depletion of Ara h 2 (1.65+/-0.15-fold; P<0.05) and assays of seven individual sera showed a similar increase in the average EC50 (1.7+/-0.2-fold; P<0.02). The percent of the anti-peanut IgE that binds Ara h 2 correlated with an increase in the EC50 of the CPE following depletion of Ara h 2 (r=0.83; P<0.02). On the other hand, data from three of these patients studied with a basophil histamine release assay did not show a significant effect of depletion of Ara h 2.
CONCLUSION: Based on its ability to cross-link IgE effectively, Ara h 2 is clearly an important peanut allergen. Its ability to cross-link IgE effectively from a specific serum is related to the proportion of anti-Ara h 2 in that serum but Ara h 2 does not account for a majority of the effector activity of the CPE for any of the sera studied.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456223     DOI: 10.1111/j.1365-2222.2007.02701.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  16 in total

1.  The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.

Authors:  M Kulis; X Chen; J Lew; Q Wang; O P Patel; Y Zhuang; K S Murray; M W Duncan; H S Porterfield; A W Burks; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2012-02       Impact factor: 5.018

2.  Effect of chemical modifications on allergenic potency of peanut proteins.

Authors:  Ramon Bencharitiwong; Hanneke P M van der Kleij; Stef J Koppelman; Anna Nowak-Węgrzyn
Journal:  Allergy Asthma Proc       Date:  2015 May-Jun       Impact factor: 2.587

3.  Variable IgE cross-reactivity between peanut 2S-albumins: The case for measuring IgE to both Ara h 2 and Ara h 6.

Authors:  Stéphane Hazebrouck; Blanche Guillon; Evelyne Paty; Stephen C Dreskin; Karine Adel-Patient; Hervé Bernard
Journal:  Clin Exp Allergy       Date:  2019-06-05       Impact factor: 5.018

4.  Analysis of the effector activity of Ara h 2 and Ara h 6 by selective depletion from a crude peanut extract.

Authors:  Xueni Chen; Yonghua Zhuang; Qian Wang; Daphne Moutsoglou; Glenn Ruiz; S-E Yen; Stephen C Dreskin
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

5.  Ara h 2 and Ara h 6 have similar allergenic activity and are substantially redundant.

Authors:  Xueni Chen; Qian Wang; Rabab El-Mezayen; Yonghua Zhuang; Stephen C Dreskin
Journal:  Int Arch Allergy Immunol       Date:  2012-10-16       Impact factor: 2.749

6.  Clinical efficacy and immune regulation with peanut oral immunotherapy.

Authors:  Stacie M Jones; Laurent Pons; Joseph L Roberts; Amy M Scurlock; Tamara T Perry; Mike Kulis; Wayne G Shreffler; Pamela Steele; Karen A Henry; Margaret Adair; James M Francis; Stephen Durham; Brian P Vickery; Xiaoping Zhong; A Wesley Burks
Journal:  J Allergy Clin Immunol       Date:  2009-07-03       Impact factor: 10.793

7.  Nanoallergens: A multivalent platform for studying and evaluating potency of allergen epitopes in cellular degranulation.

Authors:  Peter E Deak; Maura R Vrabel; Vincenzo J Pizzuti; Tanyel Kiziltepe; Basar Bilgicer
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-13

8.  Epitope analysis of Ara h 2 and Ara h 6: characteristic patterns of IgE-binding fingerprints among individuals with similar clinical histories.

Authors:  K Otsu; R Guo; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

9.  Effector activity of peanut allergens: a critical role for Ara h 2, Ara h 6, and their variants.

Authors:  H S Porterfield; K S Murray; D G Schlichting; X Chen; K C Hansen; M W Duncan; S C Dreskin
Journal:  Clin Exp Allergy       Date:  2009-05-11       Impact factor: 5.018

Review 10.  Redefining the major peanut allergens.

Authors:  Yonghua Zhuang; Stephen C Dreskin
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.